Skip to content

AMN Healthcare AMN Pre-tax stock-based compensation cost

Pre-tax stock-based compensation cost at other companies

Avanos Medical logo
Avanos MedicalAVNS
Healthcare Services Group logo
Healthcare Services GroupHCSG
Solventum logo
SolventumSOLV

Other financials

Income statement

See full
Revenue$1.4B+99.9%
Gross profit$368.8M+86.2%
Operating income$117.2M+837%
Net income$62.2M+5,793%
EPS (diluted)$1.59+5,400%

Balance sheet

See full
Cash & equivalents$595.0M+528%
Total debt$776.9M-12.4%
Total equity$712.8M-0.3%
Total assets$2.6B+8.7%

Cash flow

See full
Operating cash flow$562.5M+507%
CapEx$7.2M-27.4%
Free cash flow$555.2M+571%

Valuation

See full
Market cap$1.23B-24.1%
Enterprise value$1.41B-48.4%
P/S0.4×-0.2×

Profitability

See full
Gross margin27.6%-2.5pp
Operating margin-9.8%-14.2pp
Net margin-0.9%-0.4pp
FCF margin20.7%+11.6pp

Returns & leverage

See full
Return on equity-4.5%-2.0pp
Debt / equity1.1×-0.2×
Current ratio1.1×0.0×

Where this comes from

Reported directly by AMN Healthcare in its filing.

Tagged under the XBRL concept us-gaap:AllocatedShareBasedCompensationExpense.

The official record: AMN Healthcare’s 10-K, filed February 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about AMN Healthcare's pre-tax stock-based compensation cost.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AMN Healthcare's pre-tax stock-based compensation cost?
AMN Healthcare (AMN) reported pre-tax stock-based compensation cost of $7.67M in Q4 2025.
How has AMN Healthcare's pre-tax stock-based compensation cost changed year-over-year?
AMN Healthcare's pre-tax stock-based compensation cost increased by 31.6% year-over-year, from $5.83M to $7.67M.
What is the long-term trend for AMN Healthcare's pre-tax stock-based compensation cost?
Over 4 years (2021 to 2025), AMN Healthcare's pre-tax stock-based compensation cost has grown at a 5.0% compound annual growth rate (CAGR), from $25.22M to $30.68M.